Blueprint Medicines Corporation (BPMC) Financials
BPMC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 1.0 billion | 918.6 million |
2023-09-30 | 1.1 billion | 902.7 million |
2023-06-30 | 1.1 billion | 795.3 million |
2023-03-31 | 1.2 billion | 806.1 million |
BPMC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -83.6 million | 22.6 million |
2023-09-30 | -110.7 million | 23.1 million |
2023-06-30 | -133.0 million | 23.8 million |
2023-03-31 | -125.5 million | 23.2 million |
BPMC Net Income
No data available :(
BPMC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 710.6 million | - | 93.7 million |
2023-09-30 | 827.2 million | - | 95.7 million |
2023-06-30 | 836.6 million | 531.1 million | 98.3 million |
2023-03-31 | 961.3 million | 535.3 million | 100.8 million |
BPMC Shares Outstanding
BPMC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 4.7 million | 96.0 million | 79.3 million | - |
2023-09-30 | 6.3 million | 110.3 million | 57.7 million | 13.1 million |
2023-06-30 | 2.6 million | 110.1 million | 53.2 million | 18.7 million |
2023-03-31 | 2.6 million | 112.1 million | 71.0 million | - |
BPMC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 72.0 million | 1.8 million |
2023-09-30 | 56.6 million | 4.6 million |
2023-06-30 | 57.6 million | 2.3 million |
2023-03-31 | 63.3 million | 3.2 million |
BPMC
Price: $93
52 week price:
Earnings Per Share: -8.37 USD
P/E Ratio: -8.65
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 807200
Ebitda: -37.3 millionMarket Capitalization: 5.6 billion